Edition:
India

Vitamin Shoppe Inc (VSI.N)

VSI.N on New York Stock Exchange

10.45USD
23 Jun 2017
Change (% chg)

$0.40 (+3.98%)
Prev Close
$10.05
Open
$9.95
Day's High
$10.45
Day's Low
$9.90
Volume
253,513
Avg. Vol
108,529
52-wk High
$32.27
52-wk Low
$9.80

VSI.N

Chart for VSI.N

About

Vitamin Shoppe, Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super... (more)

Overall

Beta: 0.70
Market Cap(Mil.): $249.19
Shares Outstanding(Mil.): 23.85
Dividend: --
Yield (%): --

Financials

BRIEF-Vitamin Shoppe sees FY 2017 adjusted EPS $1.50-$1.75 excluding items

* Q1 earnings per share view $0.57 -- Thomson Reuters I/B/E/S

10 May 2017

BRIEF-The Vitamin Shoppe appoints two new members to board of directors

* The vitamin Shoppe appoints two new members to board of directors

07 Apr 2017

BRIEF-Vitamin Shoppe Inc Q4 GAAP loss per share $0.49

* Q4 earnings per share view $0.40 -- Thomson Reuters I/B/E/S

01 Mar 2017

BRIEF-Fuller & Thaler Asset Management reports 7.4 pct passive stake in vitamin Shoppe Inc as of Dec. 31

* Fuller & Thaler Asset Management Inc reports a 7.4 percent passive stake in vitamin Shoppe Inc as of December 31, 2016-sec filing Source text (http://bit.ly/2lcrbqG) Further company coverage:

23 Feb 2017

BRIEF-Vitamin Shoppe announces changes to board of directors

* Company will add two new independent directors in next two months.

22 Feb 2017

France to suspend sales of Vitamin D supplement after infant's death

PARIS France has started measures to suspend sales of a Vitamin D supplement marketed as Uvesterol D after the death of a baby who had been given a dose of it, a French medical safety watchdog said on Wednesday.

05 Jan 2017

France to suspend sales of Vitamin D supplement after infant's death

PARIS France has started measures to suspend sales of a Vitamin D supplement marketed as Uvesterol D after the death of a baby who had been given a dose of it, a French medical safety watchdog said on Wednesday.

05 Jan 2017

More From Around the Web

Earnings vs. Estimates